Diabetes mellitus-Progress and opportunities in the evolving epidemic

被引:18
作者
Abel, E. Dale [1 ]
Gloyn, Anna L. [2 ]
Evans-Molina, Carmella [3 ]
Joseph, Joshua J. [4 ]
Misra, Shivani [5 ,6 ]
Pajvani, Utpal B. [7 ]
Simcox, Judith [8 ]
Susztak, Katalin [9 ]
Drucker, Daniel J. [10 ,11 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[2] Stanford Univ, Sch Med, Stanford Diabet Res Ctr, Dept Genet,Dept Pediat,Div Endocrinol & Diabet, Stanford, CA USA
[3] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA
[4] Ohio State Univ, Coll Med, Div Endocrinol Diabet & Metab, Columbus, OH USA
[5] Imperial Coll London, Dept Metab Digest & Reprod, London, England
[6] Imperial Coll NHS Trust, London, England
[7] Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA
[8] Univ Wisconsin, Howard Hughes Med Inst, Dept Biochem, Madison, WI USA
[9] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA USA
[10] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[11] Univ Toronto, Dept Med, Toronto, ON, Canada
基金
英国惠康基金; 加拿大健康研究院; 美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
FATTY LIVER-DISEASE; HIGH-SENSITIVITY TROPONIN; MYOCARDIAL INJURY THRESHOLDS; BETA-CELL DYSFUNCTION; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; AIR-POLLUTION; DOUBLE-BLIND; NONALCOHOLIC STEATOHEPATITIS; ENDOTHELIAL DYSFUNCTION;
D O I
10.1016/j.cell.2024.06.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads to complications that reduce quality of life and increase mortality. Diabetes pathophysiology includes dysfunction of beta cells, adipose tissue, skeletal muscle, and liver. Type 1 diabetes (T1D) results from immune-mediated beta cell destruction. The more prevalent type 2 diabetes (T2D) is a heterogeneous disorder characterized by varying degrees of beta cell dysfunction in concert with insulin resistance. The strong association between obesity and T2D involves pathways regulated by the central nervous system governing food intake and energy expenditure, integrating inputs from peripheral organs and the environment. The risk of developing diabetes or its complications represents interactions between genetic susceptibility and environmental factors, including the availability of nutritious food and other social determinants of health. This perspective reviews recent advances in understanding the pathophysiology and treatment of diabetes and its complications, which could alter the course of this prevalent disorder.
引用
收藏
页码:3789 / 3820
页数:32
相关论文
共 306 条
  • [1] The impact of air quality on cardiovascular health: A state of the art review
    Abdul-Rahman, Toufik
    Roy, Poulami
    Bliss, Zarah Sophia Blake
    Mohammad, Abdulkader
    Corriero, Anna Chiara
    Patel, Neal T.
    Wireko, Andrew Awuah
    Shaikh, Raheel
    Faith, Ogungbemi Evelyn
    Arevalo-Rios, Einer Carlos Eduardo
    Dupuis, Leonie
    Ulusan, Sebahat
    Erbay, Muhammed Ibrahim
    Cedeno, Mario Villalobos
    Sood, Aayushi
    Gupta, Rahul
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (02)
  • [2] Insulin signaling in the heart
    Abel, E. Dale
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 321 (01): : E130 - E145
  • [3] Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
    Ahlqvist, Emma
    Storm, Petter
    Karajamaki, Annemari
    Martinell, Mats
    Dorkhan, Mozhgan
    Carlsson, Annelie
    Vikman, Petter
    Prasad, Rashmi B.
    Aly, Dina Mansour
    Almgren, Peter
    Wessman, Ylva
    Shaat, Nael
    Spegel, Peter
    Mulder, Hindrik
    Lindholm, Eero
    Melander, Olle
    Hansson, Ola
    Malmqvist, Ulf
    Lernmark, Ake
    Lahti, Kaj
    Forsen, Tom
    Tuomi, Tiinamaija
    Rosengren, Anders H.
    Groop, Leif
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (05) : 361 - 369
  • [4] Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
    Angulo, Paul
    Kleiner, David E.
    Dam-Larsen, Sanne
    Adams, Leon A.
    Bjornsson, Einar S.
    Charatcharoenwitthaya, Phunchai
    Mills, Peter R.
    Keach, Jill C.
    Lafferty, Heather D.
    Stahler, Alisha
    Haflidadottir, Svanhildur
    Bendtsen, Flemming
    [J]. GASTROENTEROLOGY, 2015, 149 (02) : 389 - +
  • [5] Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study
    Anjana, Ranjit Mohan
    Baskar, Viswanathan
    Nair, Anand Thakarakkattil Narayanan
    Jebarani, Saravanan
    Siddiqui, Moneeza Kalhan
    Pradeepa, Rajendra
    Unnikrishnan, Ranjit
    Palmer, Colin
    Pearson, Ewan
    Mohan, Viswanathan
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [6] [Anonymous], 2013, World Health Organization: What are the Social Determinants of Health?.
  • [7] Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
    Aroda, Vanita R.
    Aberle, Jens
    Bardtrum, Lars
    Christiansen, Erik
    Knop, Filip K.
    Gabery, Sanaz
    Pedersen, Sue
    Buse, John B.
    [J]. LANCET, 2023, 402 (10403) : 693 - 704
  • [8] A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
    Asgharpour, Amon
    Cazanave, Sophie C.
    Pacana, Tommy
    Seneshaw, Mulugeta
    Vincent, Robert
    Banini, Bubu A.
    Kumar, Divya Prasanna
    Daita, Kalyani
    Min, Hae-Ki
    Mirshahi, Faridoddin
    Bedossa, Pierre
    Sun, Xiaochen
    Hoshida, Yujin
    Koduru, Srinivas V.
    Contaifer, Daniel, Jr.
    Warncke, Osinska
    Wijesinghe, Dayanjan S.
    Sanyal, Arun J.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 65 (03) : 579 - 588
  • [9] Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans
    Bachmann, OP
    Dahl, DB
    Brechtel, K
    Machann, J
    Haap, M
    Maier, T
    Loviscach, M
    Stumvoll, M
    Claussen, CA
    Schick, F
    Häring, HU
    Jacob, S
    [J]. DIABETES, 2001, 50 (11) : 2579 - 2584
  • [10] Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
    Back, Magnus
    Yurdagul, Arif, Jr.
    Tabas, Ira
    Oorni, Katariina
    Kovanen, Petri T.
    [J]. NATURE REVIEWS CARDIOLOGY, 2019, 16 (07) : 389 - 406